- Benchmark ASINB0H28FK968
- MarketplaceUS
- Category ID13053141
- Analyzed Products
- Keywordhome health care
- Price Range-
- Minimum Net Profit Margin10.00%
- MOQ100
- Est. Purchasing Cost¥17.99estimated
- Data Date2026-08-01
- Your Budget (for new listing) (CNY)¥500,000.00
Report summary from Keble AI Agent: Listing
结论很明确：这个市场目前不值得进入。 虽然表面上只有 1 个新品牌 RERIIBE 的新产品跑通了，但这更像单点成功，不是可复制的市场机会；没有看到新品牌涌入，也没有看到明确的价格战爆发，但样本太少，不能把它当成稳定机会。
证据上，当前可见的新品牌只有 1 个，成功率 100%，但样本量只有 1 个，参考意义很弱。 唯一成功样本是 RERIIBE 的 B0H28FK968，售价 $29.99，月销 300 件，月营收 $8,997，利润率 33.14%，早期投入约 $12,894.50；它能赚钱的核心不是砸钱，而是功能差异化+低价：便携可穿戴理疗包带式结构，660nm 红光+850nm 近红外双波段，3 芯片组合，多档强度，面向肩颈、关节、肌肉放松人群。按你的规则，这个产品只有 12 条评价，不属于 200~300+ 评价的“predatory competitors”，但它已经证明：想在这个市场做出结果，至少要有明确产品差异和持续投放预算。用户 50 万 CNY 预算足够做单个 ASIN 的前期入场，但这只覆盖前几个月的供货、物流和推广，不含研发、品牌和认证；如果没有产品创新，这个预算也只是“能进场”，不是“能赢”。
- 大品牌路径：可以做，但只能按 RERIIBE 这类“差异化功能+中低价+投放驱动”的路线切入，不能指望靠品牌名直接拿市场。
- 小商家路径：目前没有看到 <300 评价/年的真实稳定成功群体可复制；唯一样本虽然评价低，但明显依赖差异化和广告，复制难度不低。
- 市场信号：没有 oversaturation 警报，但也没有足够样本证明它是健康市场；现在最关键的不是“能不能做”，而是“有没有第二、第三个可复制成功样本”。
短结论：先不要进。 这不是一个已经证明对新品牌稳定友好的市场；如果一定要看，优先跟踪 RERIIBE / B0H28FK968 这种打法，但在出现更多新品牌成功样本前，不建议下场。
Recommended Products Features Direction
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
New Brands
VS
Old Brands
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
New Brands
#Budget Requirement
Listing结论很直接：这个市场对你来说可进入，且你的50万人民币预算足够覆盖单个ASIN的前期入场，但它不是低门槛市场；真正能做出利润的，是靠“差异化功能+低价位”切进去，而不是纯靠砸钱。 目前唯一被验证的成功样本是 RERIIBE 的 B0H28FK968，售价约 $29.99，月销 300 件，月收入约 $899,700，毛利率约 33.14%，说明只要产品有明确功能差异，还是能做出结果。
Early sourcing + logistics + marketing budget (USD)N/AExplains the budgetWith all these investments, who has profitable new releases
How many new listings are released by old brands?0.00%New listing success rate (new brands):100.00%Which new brands have these successful new listings?Alternatives- 一次性热敷贴/暖贴：价格更低、即贴即用，不需要了解红光波长或设备操作，适合临时缓解肩颈、腰背和膝盖不适的用户。
- 可重复使用凝胶热敷垫：比红光理疗设备更便宜，覆盖面大，插电或微波加热即可使用，入门门槛低，适合家庭日常热敷。
- 按摩枪低价入门款：对很多想要“放松肌肉”的用户来说，操作直观、见效感更强，且市面上低价机型选择多，购买决策更简单。
- 泡脚桶/足浴盆：对于偏向放松、睡前舒缓、下肢疲劳的人群，足浴方案更容易被接受，使用场景明确，价格也通常低于红光设备。
- 肩颈/腰部加热按摩护具：如果用户核心诉求是局部保暖和舒缓，带振动或热敷功能的护具往往更便宜、更熟悉，学习成本更低。
- 理疗贴/热感贴膏：作为轻量级替代方案，价格低、携带方便、无需电源，适合对便携性和低成本更敏感的用户。
- 家用泡沫轴/筋膜放松轴：对于运动后肌肉紧张或久坐僵硬用户，属于更廉价的自助放松替代，长期使用成本更低。
Alternative solutions may pose a risk to your investment in certain markets.
#Brands Investment Analysis
Listing这个市场不值得进入：样本里只有1个可识别新款，且1个就盈利，表面上像机会，但这更像单点成功，不足以证明市场可复制。 目前没有看到新品牌大规模涌入，也没有看到价格战迹象；但也没有足够的有效样本支撑“可持续赚钱”，所以不应把它当成稳定市场。
Least investment in new productsMost investment in new productsNew products with Highest revenueRERIIBE
Recent Monthly Revenue (USD):$8,997.00(300pcs/month)B0H28FK968 (4.7/5 (12 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitable#Differentiations
Unique productsCommon productsDifferentiation:- Product features and designs are too common without differentiation
B0H28FK968 (4.7/5 (12 Reviews))Brand is a new entry in this marketNew ReleaseSufficient Sales to Meet MOQWhite HatThis listing is deemed profitableSales & BSR
#Net Profit Margins: All vs New
Listing这个市场目前不能进，结论是偏低样本但信号很清楚：只有 1 个可见样本，且这个样本已经是新品牌 RERIIBE 的新上架产品 B0H28FK968，利润率 33.1%，月销 300 件，月营收 $8,997，初始投入 $12,894.50。表面看是能赚钱，但这不是“普遍可复制”的市场证据，而是一个靠单品差异化和投入跑出来的孤例。
证据上，当前可见利润分布里，100% 的已知利润样本都落在 30%~40% 档，0% 落在 0%~30% 或负利润区间；但总样本只有 1 个，无法证明市场广度。RERIIBE 作为新入场品牌，1 个产品 1 个盈利，成功率 100%，但这类数据强烈依赖单品表现，不能直接等同于“小卖家容易成功”。这款 ASIN 的成功点很明确：便携可穿戴理疗包带式结构、660nm 红光+850nm 近红外双波段、3 芯片组合、多档强度，属于“功能差异化+低价”组合，而不是纯靠品牌力；同时它只有 12 条评价却做到 300 件/月，说明并没有出现需要大量评价堆砌的迹象。按你给的规则，评价速度没有超过 200~300/年，不属于明显的“predatory competitors”。不过，市场投资基准只有这个样本的早期投入 $12,894.50，且工具没有给出完整的可复制预算区间，说明要做出同级表现至少需要把“产品创新、前期投放、包装/认证”一起算进去，你的 50 万 CNY 预算够单品启动，但不够证明这个市场对普通小卖家是稳定友好的。**
最终判断：不建议现在进入。 这不是一个已经证明“新品牌可稳定复制成功”的市场，更不是可以判定为高胜率的小卖家机会；目前只看到 1 个新品牌成功样本，无法排除其背后依赖特殊差异化或更强投放。若一定要做，Big Brand 只能跟踪 RERIIBE / B0H28FK968 这种“功能差异化+中低价+积极投放”的路线；Small Business 也只能把它当作单点参考，不能把它当成可复制模板。
Profitability difficultyUnknown - Insufficient New ReleasesAll products distribution on different profit levels
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%otherNew products distribution on different profit levels
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
x < -10.0%-10.0% <= x < 0.0%0.0% <= x < 10.0%10.0% <= x < 20.0%20.0% <= x < 30.0%30.0% <= x < 40.0%x >= 40.0%other#Top Products by Net Profit Margin
Top 20 Profitable Products
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
B0H28FK968RERIIBE2026-05-16Yes$29.99300pcs$8997.033.14%$2981.61Top 20 Profitable New Products
Most profitable new products ranked by profit value. Only includes newly released products with positive profitability and active sales.
B0H28FK968RERIIBE2026-05-16Yes$29.99300pcs$8997.033.14%$2981.61#New Product Success Rates
Listing这个市场目前不适合进入，原因很明确：样本里虽然出现了1个新品牌RERIIBE的成功案例，但成功高度集中、样本量极小，不能代表可复制机会；同时该成功案例的早期投入高达约12,894.50美元，其中广告约3,348.70美元，说明想跑通并不便宜。 这更像是“重投放+差异化”才能做出的单点胜利，不是一个对多数新卖家友好的市场。
New products success rate.
What is the ratio of profitable products
Profitable (Unidentifiable released date)Profitable (Old product)Profitable (New product)Profitable (New product on old listing)New products but non profitableProfitable new products divide by brands
What is the ratio of different brands owning all profitable new products
RERIIBENo data available#Success Rate by Entry Time
Listing这个市场目前不值得进入：从已覆盖样本看，新增品牌几乎没有形成真实的扩张潮，但现有可见成功样本只剩下单一品牌 RERIIBE 和单个 ASIN B0H28FK968，说明市场不是机会分散型，而是被少数样本锁定；更关键的是，当前能确认的成功是新品牌新上架直接盈利，表面上看可做，但样本量太小，无法证明这是稳定窗口，反而更像“偶发成功点”。
证据上，用户预算是 500,000 CNY，而唯一可核实的成功产品 B0H28FK968 属于 RERIIBE，售价 29.99 USD，月销 300，月营收 8,997 USD，月利润 2,981.61 USD，利润率 33.1%，早期投入 12,894.50 USD，其中广告约 3,348.70 USD；这说明单个 ASIN 级别的入场资金并不高于你的预算，但这类成功需要持续广告和稳定销量，不是低成本轻松复制的类型。市场时间趋势里，2022到2025几乎没有可确认的新品牌成功样本，直到2026才出现这一个成功点，说明不是成熟红海里的普遍机会，而是非常窄的切口；同时目前可见的新品牌成功率在已识别样本里是 100%，失败率 0%，但这只是 1 个样本，不能当成真实市场成功率。由于没有看到 30~100+ 新品牌涌入，也没有看到大量低于 10% 利润率的样本，暂时不能把它定义成全面过热的价格战市场，但也绝对不能据此判断为可大规模进入的好市场。
对两类卖家结论都一样：大品牌可考虑观察，小商家不建议进场。大品牌如果硬要切入，应只跟踪 RERIIBE / B0H28FK968 这种 白帽新上架、33.1% 利润率、300月销量、12个评价 的打法，但这不是“安全标杆”，只是一个单点样本；小商家这边没有看到 <300 评价/年 的稳定真实成功群体可作为参考，现有成功样本本身就只有 12 个评价，极可能依赖较强广告推动，复制成本未必低。结论很明确：不要现在进入，先继续观察是否会出现更多新品牌和更多可重复的高利润新上架样本。
How many products released each year
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
How many products released each month
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
#Net Profit Margins by Entry Time
Different profit ratios of products released in year
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2022 0 0 0 0 0 0 0 0 2023 0 0 0 0 0 0 0 0 2024 0 0 0 0 0 0 0 0 2025 0 0 0 0 0 0 0 0 2026 0 0 0 0 0 1 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiableDifferent profit ratios of products released in month
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
Time/Profit% x < -10.0% -10.0% <= x < 0.0% 0.0% <= x < 10.0% 10.0% <= x < 20.0% 20.0% <= x < 30.0% 30.0% <= x < 40.0% x >= 40.0% other 2025/8 0 0 0 0 0 0 0 0 2025/9 0 0 0 0 0 0 0 0 2025/10 0 0 0 0 0 0 0 0 2025/11 0 0 0 0 0 0 0 0 2025/12 0 0 0 0 0 0 0 0 2026/1 0 0 0 0 0 0 0 0 2026/2 0 0 0 0 0 0 0 0 2026/3 0 0 0 0 0 0 0 0 2026/4 0 0 0 0 0 0 0 0 2026/5 0 0 0 0 0 1 0 0 2026/6 0 0 0 0 0 0 0 0 2026/7 0 0 0 0 0 0 0 0 ≥ 10% Profitable< 10% UnprofitableUnidentifiable#Case Study
Success CasesRed Light Therapy, Portable Red Light Therapy for Body Knee Back Shoulder Hands,660nm & 850nm with 180 LEDs, 3 Chips in 1 Wearable Flexible Infrared Light Heating Wrap Belt Gift for Women Men
This listing is deemed profitablePrice (USD)$29.99Released TypeNew Release (2026-05-16)Brand is a new entry in this marketSize and Weight30.1 x 18.2 x 1.8 cm, 295.00gProfitable Factors
Distinct functions and featuresLow pricing strategyDesign & Appearance
便携可穿戴理疗包带式结构，配双长短绑带，适配腰腹、膝肘、手脚等多部位Key Buying Motive
660nm红光+850nm近红外双波段，且采用3芯片组合与多档强度调节，强调家庭日常多部位热敷理疗Target Customers
适合需要在家进行肩颈、关节、肌肉日常放松的人群，尤其是中老年、久坐办公族和运动后恢复用户Early Investment
Investment
Monthly Revenue (Recent) (USD)$8,997.00300 sold in the past 30 days · as of 2026年8月Net Profit Margin
Sea Freight31.88% / 33.14%Peak / Non PeakRail Freight- / -Peak / Non PeakAir Freight27.07% / 28.34%Peak / Non PeakSales & BSR Performance